Recalls / Active ingredient / Scopolamine
Scopolamine
2 FDA drug recalls involving the active ingredient “Scopolamine”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-04-13 | Class II | Transderm Scop (scopolamine) Transdermanl System, 1 mg/ 3 days, 10 (patches) transdermal Systems Multipack, Rx | Mckesson Medical-Surgical Inc. Corporate Office |
| 2018-05-11 | Class II | Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) 4-count (NDC 45802-580-84); b) 10-count (NDC 45802 | L. Perrigo Company |